ID
26274
Beschrijving
Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 Ongoing Record: Adverse Events
Trefwoorden
Versies (1)
- 15-10-17 15-10-17 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
15 oktober 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC-ND 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Adverse Events Ropinirole in Parkinson's Disease GSK 101468/196
Adverse Events Ropinirole in Parkinson's Disease GSK 101468/196
- StudyEvent: ODM
Beschrijving
Adverse Events
Alias
- UMLS CUI-1
- C0877248
Beschrijving
If YES, indicate below.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0877248
Beschrijving
Adverse Event Diagnosis
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0011900
Beschrijving
* A Serious Adverse Event is any AE that is fatal, life-threatening , disabling/incapacitating, results in inpatient hospitalization or prolongation of existing hospitalization, or a congenital anomaly/birth defect. Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a serious adverse drug experience when, based upon appropriate medical judgement, they may jeopardise the patient and may require medical or surgical intervention to prevent one of the outcomes listed in this definition. Cancer, overdose and pregnancy must also be reported on SAE form. Record any Serious Adverse Events on the Serious Adverse Event from and notify the PAREXEL Clinical Trial Safety Center within 24 hours of learning of its occurence
Datatype
boolean
Alias
- UMLS CUI [1]
- C1710056
Beschrijving
Start Date
Datatype
date
Maateenheden
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0808070
Beschrijving
Start Time
Datatype
time
Maateenheden
- 24hr:min
Alias
- UMLS CUI [1]
- C1301880
Beschrijving
If ongoing, please eave blank.
Datatype
date
Maateenheden
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0806020
Beschrijving
End Time
Datatype
time
Maateenheden
- 24hr:min
Alias
- UMLS CUI [1]
- C1522314
Beschrijving
Adverse Event: Intensity
Datatype
integer
Alias
- UMLS CUI [1]
- C1710066
Beschrijving
Relationship to Drug
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0439849
Beschrijving
Action Taken
Datatype
integer
Alias
- UMLS CUI [1]
- C2826626
Beschrijving
If YES, record on Other (non-study) Medications Form.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Beschrijving
Event Course
Datatype
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Beschrijving
Number of Adverse Events
Datatype
float
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0449788
Beschrijving
Adverse Event Outcome
Datatype
integer
Similar models
Adverse Events Ropinirole in Parkinson's Disease GSK 101468/196
- StudyEvent: ODM
C0011900 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])